Dawn Viveash
2009
In 2009, Dawn Viveash earned a total compensation of $1.1M as Senior Vice President, Regulatory Affairs at Orexigen Therapeutics.
Compensation breakdown
| Bonus | $24,000 |
|---|---|
| Option Awards | $785,620 |
| Salary | $54,167 |
| Other | $225,046 |
| Total | $1,088,833 |
Viveash received $785.6K in option awards, accounting for 72% of the total pay in 2009.
Viveash also received $24K in bonus, $54.2K in salary and $225K in other compensation.
Rankings
In 2009, Dawn Viveash's compensation ranked 4,173rd out of 9,885 executives tracked by ExecPay. In other words, Viveash earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,173 out of 9,885 | 58th |
Division Manufacturing | 1,483 out of 3,690 | 60th |
Major group Chemicals And Allied Products | 282 out of 866 | 67th |
Industry group Drugs | 169 out of 638 | 74th |
Industry Pharmaceutical Preparations | 133 out of 446 | 70th |
Source: SEC filing on April 28, 2010.
Viveash's colleagues
We found seven more compensation records of executives who worked with Dawn Viveash at Orexigen Therapeutics in 2009.
2009
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2009
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2009
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2009
Heather Turner
Orexigen Therapeutics
General Counsel
2009
Eckard Weber
Orexigen Therapeutics